Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, JVN

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals


DuPonttm Liveotm Healthcare and ST combine to create a new concept in wearable biosignal-monitoring devices that merges patient comfort with high performance.

WILMINGTON, Del., Nov. 2, 2023 /PRNewswire/ -- DuPont (NYSE:DD) today announced that DuPonttm Liveotm Healthcare Solutions is collaborating with STMicroelectronics (NYSE: STM), a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring.

"Dedicated Liveotm research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications ? including smart devices that can share data between patients and doctors," said DuPonttm Liveotm Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPonttm Liveotm Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont."

By collaborating with others across the healthcare ecosystem ? from technology developers and material suppliers to device fabricators and OEMs ? DuPont is developing more patient-centric solutions that contribute to better patient outcomes.

"ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware,  and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs," said Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. "The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPonttm Liveotm materials used to create the patch."

Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPonttm Liveotm Soft Skin Conductive Tape 1-3150 ? a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveotm Soft Skin Adhesives.

ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveotm Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days.

DuPont also designed the layout for the Liveotm Smart Biosensing Patch and supplied rapid prototyping capabilities.

The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveotm Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring.

The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable.

DuPont will demonstrate the capabilities of the Liveotm Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveotm team will be in Hall 12/D33 in the Wearable Technologies Pavilion.

As part of the MEDICA Connected Healthcare Forum, DuPonttm Liveotm Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37.

DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance.

Whether for drug delivery or smart monitoring devices, DuPonttm Liveotm Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology. Learn more about Liveotm brand products for medical device applications at liveo.dupont.com.

About DuPonttm Liveotm Healthcare Solutions
DuPonttm Liveotm is a globally recognized leader in technology for a broad range of innovations in medical devices, biopharmaceutical processing and pharmaceutical solutions. DuPont high-performance materials help create safer healthcare environments and protect the health of patients and healthcare providers worldwide. We help enable smarter healthcare and positive patient outcomes. More information can be found at liveo.dupont.com

About DuPont Electronics & Industrial
DuPont Electronics & Industrial is a global supplier of new technologies and performance materials serving the semiconductor, circuit board, display, digital and flexographic printing, healthcare, aerospace, industrial, and transportation industries. From advanced technology centers worldwide, teams of talented research scientists and application experts work closely with customers, providing solutions, products and technical service to enable next-generation technologies.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPonttm, the DuPont Oval Logo, and all trademarks and service marks denoted with tm, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

SOURCE DuPont


These press releases may also interest you

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...

at 19:15
The "Europe Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The Europe cell and gene therapy manufacturing Quality Control (QC) market is expected to reach...

at 19:00
More than ever, young girls are being exposed to adult skincare content, and it's creating societal pressure for them to adopt unnecessary anti-ageing skincare regimens before they've even grown up. To view the Multimedia New Release, Please click:...

at 18:57
CalciMedica Inc. (CalciMedica or the Company) , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic diseases,...



News published on and distributed by: